ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 683334 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 683334; 2) Community: the network communities that were significantly associated with the response to NSC 683334; 3) Molecule: the relationships between components within communities and NSC 683334; 4) MDR: the compounds that were significantly associated with the NSC 683334.

NSC Compound Enrichment Correlation
NSC 728037 2-[(3,4-dicloro)anilino]-3-phenyl-5,7-diamino quinoxaline 0.030556149892922 0.23004562
NSC 742416 C4, carbonyl, ethyl prodigiosine 0.030556149892922 0.27861178
NSC 747174 Null 0.030556149892922 0.12807007
NSC 747451 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide 0.030556149892922 0.20965097
NSC 758664 Sirolimus [USAN] 0.030556149892922 -0.020192835
NSC 94600 Camptothecin 0.030556149892922 -0.011347082
NSC 154948 M-AMSA 0.0348927754043159 -0.030555178
NSC 166382 Null 0.0348927754043159 -0.041636691
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0348927754043159 0.11682894
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.0348927754043159 -0.026879984
Total:87  Current:56    [First] [Prev] [Next] [Last]